Skip to content
TrustList
BioMedPartners logo
Venture capital firm

BioMedPartners

A Swiss venture capital firm backing early-stage biotech companies in continental Europe

BioMedPartners cover

TrustList summary

BiomedVC is a life-sciences venture capital firm founded in 2021 to continue the work of its predecessor, BioMedPartners, founded in 2002. The firm backs first-time and experienced founders at seed and Series A stages, investing in continental Europe with a focus on the DACH region, particularly Switzerland and Germany, and reserves capital for follow-on rounds. It is raising a new fund, BiomedInvest IV, having already built a portfolio of biotech startups in the two countries. BioMedPartners raised more than CHF 350 million across three earlier funds and is now in the later stage of realising that portfolio. The firm's managing partner joined in 2023 after a career including a role at NRW.BANK overseeing a portfolio of 35 life-sciences companies, and involvement in several companies later sold, including Emergence, CEVEC, Scienion, Rigontec and Direvo.

Summary written by TrustList from the business's own published information, Sep 2026.

Categories & features

Ask TrustList to introduce you to BioMedPartners

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of BioMedPartners

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about BioMedPartners.

BioMedPartners alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Open-source blockchain with its own digital currency, digital assets, smart contracts and secure authentication

Single-family office investing the Israel family's assets, with a focus on private equity

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Seed-stage venture investor backing founders in technology, healthcare and other sectors